Skip to content
Sleep Study Clinical Trials

Cincinnati, Ohio

Sleep disorder clinical trials in Cincinnati, OH

24 sleep disorder studies are recruiting participants at sites in Cincinnati as of November 16, 2026, according to ClinicalTrials.gov. Sleep Study Clinical Trials can help you understand your options and connect with a study team.

Call (888) 927-8925
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Cincinnati at a glance

  • 24 studies are recruiting at a site in Cincinnati.
  • By phase: Phase 2 (6), Phase 2/3 (4), Phase 3 (10), Phase 4 (1), No phase (1), Observational (2). Studies of devices and behavioral approaches have no phase.
  • By sponsor: industry (20), university, hospital or other (4).
  • By research area: Narcolepsy (13), Sleep Apnea (8), Insomnia (3).
  • Most recent update to one of these records: November 13, 2026.

Insomnia studies recruiting in Cincinnati

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms

    • Phase 3
    • Ages 18 to 74
    • All sexes
    Sponsor
    Janssen Research & Development, LLC
    Study site
    Patient Priority Clinical Sites LLC
    Registry record
    NCT06559306 · updated
  2. Pharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS)

    • Observational
    • Ages 0 to 20
    • All sexes
    Sponsor
    Duke University
    Study site
    Cincinnati Childrens Hospital Medical Center
    Registry record
    NCT04278404 · updated
  3. Studying Solriamfetol Modulation of TAAR-1, Dopamine, and Norepinephrine in Shift Work Disorder (SUSTAIN)

    • Phase 3
    • Ages 18 to 65
    • All sexes
    Sponsor
    Axsome Therapeutics, Inc.
    Registry record
    NCT06568367 · updated

Source: ClinicalTrials.gov. Data processed . See every insomnia study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Sleep apnea studies recruiting in Cincinnati

  1. DReAMzz- Dronabinol and Acetazolamide Medication for Sleep Apnea (ZZ). Dose Confirmation Crossover Study for IHL-42X in Subjects With Obstructive Sleep Apnea.

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Incannex Healthcare Ltd
    Study sites
    CTI Clinical Research Center · Intrepid Research
    Registry record
    NCT07635563 · updated
  2. A Study of Eloralintide (LY3841136) in Participants With Obstructive Sleep Apnea and Obesity or Overweight

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Eli Lilly and Company
    Study site
    CTI Clinical Research Center
    Registry record
    NCT07369011 · updated
  3. AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Novo Nordisk A/S
    Study site
    CTI Clinical Research Center
    Registry record
    NCT07571109 · updated
  4. Down Syndrome Obstructive Sleep Apnea

    • Phase 2
    • Ages 5 to 18
    • All sexes
    Sponsor
    Brigham and Women's Hospital
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT06043440 · updated
  5. AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Novo Nordisk A/S
    Study site
    CTI Clinical Research Center
    Registry record
    NCT07571005 · updated
  6. Improving Outcomes in Pediatric Obstructive Sleep Apnea With Computational Fluid Dynamics

    • Phase 4
    • Ages 3 to 18
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT04991389 · updated
  7. Comparison of a Demand Oxygen Delivery

    • No phase
    • Ages 5 to 17
    • All sexes
    Sponsor
    Children's Hospital Medical Center, Cincinnati
    Study site
    Cincinnati Children's Hospital Medical Center
    Registry record
    NCT06609694 · updated
  8. Pediatric Post-Approval Registry

    • Observational
    • Ages 18 to 21
    • All sexes
    Sponsor
    Inspire Medical Systems, Inc.
    Study site
    Cincinnati Childrens Hospital
    Registry record
    NCT04457154 · updated

Source: ClinicalTrials.gov. Data processed . See every sleep apnea study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Narcolepsy studies recruiting in Cincinnati

  1. A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Narcolepsy

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Harmony Biosciences Management, Inc.
    Study site
    Intrepid Research, LLC
    Registry record
    NCT07675135 · updated
  2. A Study of TAK-360 in People With Narcolepsy or Idiopathic Hypersomnia

    • Phase 2/3
    • Ages 18 to 71
    • All sexes
    Sponsor
    Takeda
    Study sites
    Takeda Site 2 · Takeda Site 4
    Registry record
    NCT07646678 · updated
  3. A Study to Investigate the Effects of Cleminorexton Compared With Placebo in the Treatment of Participants With Central Disorders of Hypersomnolence

    • Phase 2/3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Centessa Pharmaceuticals (UK) Limited
    Study site
    Cincinnati, Ohio
    Registry record
    NCT07598708 · updated
  4. A Long-Term Study of ALKS 2680 in Subjects With Narcolepsy and Idiopathic Hypersomnia

    • Phase 2/3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigational Site
    Registry record
    NCT06767683 · updated
  5. A Study of TAK-360 in Adults With Narcolepsy Without Cataplexy (NT2)

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Takeda
    Study site
    Takeda Site 5
    Registry record
    NCT06952699 · updated
  6. A Study Evaluating the Efficacy and Safety of Xywav Expanded Dosing vs Placebo in Participants With Narcolepsy or IH

    • Phase 3
    • Ages 18 to 75
    • All sexes
    Sponsor
    Jazz Pharmaceuticals
    Study site
    Intrepid Research
    Registry record
    NCT07625280 · updated
  7. A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 1

    • Phase 3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigational Site
    Registry record
    NCT07455383 · updated
  8. A Study to Evaluate the Efficacy and Safety of ALKS 2680 in Adults With Narcolepsy Type 2

    • Phase 3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigational Site
    Registry record
    NCT07502443 · updated
  9. A Study to Evaluate the Efficacy, Safety and Tolerability of ALKS 2680 in Adults With Narcolepsy Type 1 (Brilliance NT1 - 304)

    • Phase 3
    • Ages 18 to 70
    • All sexes
    Sponsor
    Alkermes, Inc.
    Study site
    Alkermes Investigational Site
    Registry record
    NCT07540897 · updated
  10. A Study of TAK-360 in Adults With Narcolepsy Type 1 (Narcolepsy With Cataplexy)

    • Phase 2
    • Ages 18 to 70
    • All sexes
    Sponsor
    Takeda
    Study site
    Takeda Site 13
    Registry record
    NCT07633301 · updated
  11. A Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Centessa Pharmaceuticals (UK) Limited
    Study site
    Cincinnati, Ohio
    Registry record
    NCT06752668 · updated
  12. A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia

    • Phase 2
    • Ages 18 to 65
    • All sexes
    Sponsor
    Centessa Pharmaceuticals (UK) Limited
    Study site
    Cincinnati, Ohio
    Registry record
    NCT07096674 · updated
  13. A Study of TAK-861 for the Treatment of Selected Central Hypersomnia Conditions

    • Phase 2/3
    • Ages 16 to 70
    • All sexes
    Sponsor
    Takeda
    Study sites
    CTI Research Center · Intrepid Research
    Registry record
    NCT05816382 · updated

Source: ClinicalTrials.gov. Data processed . See every narcolepsy study recruiting in Cincinnati, OH on ClinicalTrials.gov.

Ask about studies near Cincinnati

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

More locations in Ohio

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Sleep Study Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 927-8925

or send a short form

How should we reach you?

Call